CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Aurora Backbone Company (“Aurora Backbone” or the “Firm”) (TSXV: ASG), a designer and producer of modern medical units that enhance spinal surgical procedure outcomes, right now introduced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Working Tube”.
Aurora Backbone’s Ghost Tube™ was designed to supply superior anchoring with a translucent thermoplastic physique and non-slipping titanium anchors to guarantee that minimally invasive surgical entry will keep stationary to assist surgical preparation instruments with out blocking x-ray visualization throughout surgical procedure.
“Aurora Backbone has created a number of disruptive applied sciences up to now 12 years”, mentioned Trent Northcutt, President & CEO of Aurora Backbone. ” This newly obtained patent of our GhostTube that helps our lately launched SiLO TFX SI Fusion System will enable us to assist supply of the SiLO TFX implant and create a number of new radiolucent instruments for future product traces that require a gradual and dependable bone anchoring with a repeatable medical consequence for every affected person requiring joint stabilization surgical procedure.”
Laszlo Garamszegi, Chief Expertise Officer of Aurora Backbone, added “We’re very excited to obtain one other United States patent that bolsters our rising product and mental property portfolio. Aurora will proceed being disruptive and modern by taking a look at methods to effectively ship our merchandise and create and enhance new remedy choices to enhance affected person care and total affected person outcomes.”
About Aurora Backbone
Aurora Backbone is concentrated on bringing new options to the spinal implant market by a sequence of modern, minimally invasive, regenerative spinal implant applied sciences.
Neither TSX Enterprise Change nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Change) accepts duty for the adequacy or accuracy of this launch.
Ahead-Trying Statements
This information launch comprises forward-looking info that includes substantial recognized and unknown dangers and uncertainties, most of that are past the management of Aurora Backbone, together with, with out limitation, these listed below “Danger Components” and “Cautionary Assertion Relating to Ahead-Trying Data” in Aurora Backbone’s ultimate prospectus (collectively, “forward-looking info”). Ahead-looking info on this information launch consists of info in regards to the proposed use and success of the corporate’s merchandise in surgical procedures. Aurora Backbone cautions traders of Aurora Backbone’s securities about vital elements that might trigger Aurora Backbone’s precise outcomes to vary materially from these projected in any forward-looking statements included on this information launch. Any statements that categorical, or contain discussions as to, expectations, beliefs, plans, targets, assumptions or future occasions or efficiency aren’t historic information and could also be forward-looking and should contain estimates, assumptions and uncertainties which may trigger precise outcomes or outcomes to vary unilaterally from these expressed in such forward-looking statements. No assurance will be on condition that the expectations set out herein will show to be appropriate and, accordingly, potential traders mustn’t place undue reliance on these forward-looking statements. These statements converse solely as of the date of this press launch and Aurora Backbone doesn’t assume any obligation to replace or revise them to replicate new occasions or circumstances.
Contact:
Aurora Backbone Company
Trent Northcutt
President and Chief Government Officer
(760) 424-2004
Chad Clouse
Chief Monetary Officer
(760) 424-2004
www.aurora-spine.com
Discussion about this post